CHARLOTTESVILLE – Multiple sclerosis affects nearly a million Americans.
Symptoms can include muscle spasms, stiffness, weakness, difficulty moving, depression, pain and more. There is no cure, so treatments focus on helping patients manage their symptoms, control flareups and slow the progression of the disease.
Thanks to a discovery made by a team of researchers at University of Virginia Medical Center, there is hope for those who suffer from MS and other autoimmune diseases.
On Wednesday, UVA Health neuroscientists announced in a press release that they have discovered a potential way to disrupt the chronic inflammation responsible for multiple sclerosis. UVA’s new study identifies a vital contributor to the hyperactive autoimmune response and neuroinflammation that are the hallmarks of MS.